ACTIVATION OF T AND B LYMPHOCYTES IN VITRO : III. Presence of Ia Determinants on Allogeneic Effect Factor by Armerding, Dieter et al.
ACTIVATION  OF  T  AND  B  LYMPHOCYTES  IN  VITRO 
III.  Presence  of Ia Determinants  on  Allogeneic  Effect  Factor* 
By DIETER ARMERDING,$ DAVID H. SACHS, AND DAVID H. KATZ 
{From the Department o[ Pathology, Harvard Medical School, Boston, Massachusetts  02115 and. 
the Immunology Branch, National  Cancer Institute, National Institutes of Health, 
Bethesda,  Maryland 20014) 
Previous  studies  from  our  laboratory  have  focused  on  the  biological  and 
biochemical  properties  of  an  active  product  obtained  from  populations  of 
activated  T  lymphocytes  during  short-term  in  vitro  reactions  with  foreign 
alloantigens  (1). The active product of supernates from such cultures, which we 
have termed  allogeneic effect factor  (AEF), was shown to be capable of acting 
directly on B  lymphocytes, in the  presence of antigen,  to effect triggering  and 
subsequent  differentiation  and proliferation  to antibody-forming  cells in vitro. 
The  chromatographically  purified  active  fraction  of AEF  was  found  to  be  a 
protein moiety of 30,000-40,000 daltons (1). The active molecule(s), although not 
manifesting specificity for antigens against which the in vitro antibody responses 
were directed,  did exhibit some strain-specific  properties suggesting a  relation- 
ship  to  antigens  or gene  products  coded in  the  major histocompatibility  gene 
complex. 
Recently,  investigations  in several laboratories  using antilymphoid  cell anti- 
sera prepared between recombinant mice differing at genes present in the/region 
of the H-2 complex identified a new antigen system, which has been termed Ia, 
coded  for  by genes  in  the  I  region;  the  Ia  antigens  have  been  found  to  exist 
predominantly  on  B  cells and  macrophages  and  to varying extents  on T  cells 
(reviewed in ref.  2).  Accordingly, the possibility must be considered that  gene 
products in this region may be involved in regulatory cell interactions in immune 
responses. The experiments presented in this paper demonstrate that the active 
enhancing  factor(s)  in  AEF can be removed by an  immunoadsorbent  prepared 
with  an  anti-Ia  antiserum  indicating  that,  indeed,  the  biologically  active 
moieties responsible for T-B cell interactions  are probably products of genes in 
the I region of the H-2 gene complex. 
Materials  and  Methods 
The tissue culture system and the assay for in vitro antibody responses  to sheep erythrocytes (SRBC), 
the  preparation of anti-8  serum,  and the  method employed for  depletion of T  lymphocytes are 
described elsewhere (1, 3). Inbred DBA/2, (C3H x  DBA/2)F~ (C3D2F1),  (C57BL/6)  x  A)F~ (B6AF~), 
C57BL/10 (B10) and congenic B10.A and B10.D2 mice were obtained from Jackson Laboratories, Bar 
Harbor,  Maine. The  AEF employed in this study was  prepared from DBA/2  (H-2  d)  thymocytes 
activated against C3H (H-2  ~) histocompatibility antigens, as previously described (1). 
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The alloantisera (or Ehrlichs ascites from the same donor animals) employed were prepared and 
tested for serological reactivity as described in detail previously by Sachs and Cone (4). The following 
antisera were used: (a) B10.A anti-B10--this antiserum contains antibodies directed against antigens 
coded for by the H*2  b gene complex; it cross-reacts with antigens coded by genes in the I region of H-2  d 
(Ia.8)  but  not  with  antigens  coded by genes  in  either the  K  or D  regions of H-2d;  b)  (B6A)F 1 
anti-B10.D2--this  antiserum  contains  predominantly antibodies reactive with  specificity H-2.31 
present on cells from animals with the H-2" allele; it does not contain anti-Ia.8 activity. Although at 
the initiation of these studies there were no known antibodies reactive with the Iad specificities in this 
antiserum, subsequent analyses have demonstrated the presence of antibodies reactive with a new Ia 
specificity present also in H-2  d (5). Polyvalent rabbit antimouse immunoglobulin (Ig) antisera were 
prepared as described previously (6). 
Immunoadsorbents  were  prepared  by  the  method  of Avrameas  and  Ternyck  (7)  by  direct 
polymerization of immune or normal sera with glutaraldehyde at pH 5.0. Unfractionated AEF were 
absorbed either (a)  directly with excess  immunoadsorbents prepared from alloantisera or control 
normal sera in a batchwise procedure, or (b) indirectly by incubation first with the alloantisera or 
normal sera (at a ratio of 6 parts AEF to 1 part serum) for i h at room temperature and the absorption 
of the resulting complex with a  rabbit antimouse Ig immunoadsorbent. The absorbed AEF were 
assayed for biological activity as 1:10 (direct absorption) or 1:15 (indirect absorption) dilutions after 
filtration through 0.45 t~ Millipore filters (Millipore Corp., Bedford, Mass.). 
Results 
Two types of experiments utilizing the AEF prepared from DBA/2 (H-2  ~) T  cells 
will be presented in this study. In the first (Fig. 1), three different concentrations 
of AEF  were  directly absorbed  independently  by  immunoadsorbents  prepared 
from (B6A)F1 anti-B10.D2 and B10.A anti-B10 alloantisera and by an adsorbent 
prepared  from  normal  B10.A  serum.  These  AEF  were  then  compared  to 
unabsorbed  AEF  for  biological  activity  on  the  in  vitro  response  to  SRBC  of 
DBA/2  B  lymphocytes.  As shown  in Fig.  1,  cultures of untreated  control whole 
spleen cells developed primary  IgG anti-SRBC  responses  of around  1,200 PFC; 
anti4~-treatment  diminished  this  response  to  around  150 PFC.  The  addition of 
unabsorbed  AEF to such anti-0 serum-treated  B  cells reconstituted and enriched 
the response markedly and in a dose-related manner at all three concentrations of 
AEF  employed.  The  AEF  subjected  to  the  adsorbent  prepared  from  normal 
B10.A serum exhibited virtually identical biological activity. The AEF obtained 
from the immunoadsorbent  prepared from  (B6A)F1 anti-B10.D2  serum retained 
essentially normal  biological activity at the highest concentration  (1:5),  but the 
lowest  concentration  subjected  to  absorption  (1:20)  was  around  45%  lower  in 
activity  than  the  normal  serum  control.  The  AEF  subjected  to  the  B10.A 
anti-B10  (anti-Ia)  immunoadsorbent,  on  the  other  hand,  exhibited  markedly 
diminished  (80%  or  more)  activity  at  all  three  concentrations  indicating 
substantial reactivity of this antiserum  with the biologically active component(s) 
of AEF. 
The second type of experiment was a  modification of the preceding one in that 
an  indirect  absorption  procedure  was  employed.  Thus,  AEF  was  reacted  first 
with  either  of  the  two  alloantisera  or  normal  serum  and  the  mixture  was 
subsequently subjected to an immunoadsorbent  prepared from polyvalent rabbit 
antimouse  Ig  antiserum.  The  results  of  this  experiment,  shown  in  Table  I, 
corroborate the results of the first experiment. Thus, anti-0 serum-treated  DBA/2 ARMERDING ET AL.  BRIEF DEFINITIVE REPORT  1719 
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CONCENTRATION OF  AEF 
SUBdECTED  TO  ABSORPTION 
FIo.  1.  Removal of biological activity of AEF  derived from DBM2  (H-2  d)  T  cells  by an 
anti-Ia  d immunoadsorbent. Three  different concentrations  of AEF  were subjected  to  im- 
munoac~orbents prepared from either normal B10.A serum or from (B6A)FI anti-B10.D2  or 
B10.A anti-B10 (anti-la  d) ascites. These AEF were then tested and compared to unabsorbed 
AEF for activity on the in vitro response  to SRBC of anti-~ serum-treated DBA/2 spleen cells. 
Control responses of whole spleen cel|s and anti-0-treated cells in the absence of AEF are 
shown to the ]eft. The IgG antibody responses  are presented and paral]e|ed the IgM response 
pattern of these same cultures  (not shown). 
spleen cells, which fail to respond to SRBC in culture in the absence of AEF, (cf. 
cultures I and II) are reconstituted in their responsiveness when AEF is added to 
the culture (III). In this experiment, AEF activity was not affected by exposure to 
either normal mouse serum or the (B6A)F~  anti-B10.D2 antiserum followed by 
absorption by the antimouse Ig adsorbent (cultures IV and V) whereas the B10.A 
anti-B10 sera completely removed all biological activity (culture VI). 
Discussion and Summary 
Observations  from  our  own  laboratories,  as  well  as  those  of  others,  have 
demonstrated the critical role of histocompatibility gene products in governing 
the cell-cell interactions concerned with development and regulation of immune 
responses in several species (8-12). In mice, the relevant genes concerned have 
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TABLE I 
Biological Activity o/ AEF on In Vitro Responses o/ DBA/2 B Lymphocytes after Indirect 
Absorption  by AUoantisera and an Antimouse Immunoglobulin  Immunoadsorbent* 
Cultured DBA/2  Antiserum  Anti-SRBC 
Culture  AEF 
cells  treatment  S  response§ 
I  Whole spleen  -  -  690 
II  Anti-8 serum-  -  -  20 
treated spleen 
III  "  +  840 
IV  "  +  Normal mouse serum  660 
V  "  +  (B6A)FI anti-B10.D2  740 
VI  "  +  B10.A anti-B10  0 
* DBA/2  whole  spleen  or  anti-t~  serum-treated  spleen  cells  were  cultured  either  alone  or  with 
unabsorbed or absorbed AEF (1:15)  in the absence or presence of SRBC. 
$ AEF was incubated for 1 h  at room temperature with the sera indicated and then the mixture was 
subjected to an immunoadsorbent prepared from rabbit antimouse immunoglobulin antiserum. 
§ IgG PFC  per 10 7 cultured cells. 
regions (13, 14). These discoveries have placed histocompatibility gene products 
on  a  more  complex  level  of biologic  function than  was  heretofore  generally 
considered (15).  Thus,  the hypothesis was made from these observations that 
genes  in the H-2  complex coded for products  involved in  the development of 
effective cell-cell  interactions  in  the  immune response  (8,  9,  15).  The  recent 
identification of cell surface macromolecules on lymphocytes and macrophages, 
that may be distinct from immune response gene products but are likewise coded 
for by genes in the I region, has provided a group of suitable candidate molecules 
for such a role (2). 
In our initial studies on the biological and biochemical characteristics of AEF, 
we were impressed by the apparent preferential activity of the highly purified 
AEF preparations on B lymphocytes syngeneic to the activated T-cell population 
from which the AEF was obtained (1).  Since a prediction of the aforementioned 
hypothesis  is,  of  course,  that  the  active  molecules  involved  in  regulatory 
immunocompetent cell interactions are gene products of the H-2 complex, and, 
accordingly, should be reactive with antisera directed against components of this 
complex,  we  were  prompted  to  perform  the  appropriate  analyses  on  our 
preparation of AEF. 
The experiments presented here demonstrate that the enhancing activity of 
AEF obtained from T  cells of the H-2  ~ haplotype can be specifically removed by 
immunoadsorbents prepared from antisera reactive with Ia molecules of the H-2  d 
allele.  Identical  results  were  obtained  in  experiments  with  both  direct  and 
indirect absorption procedures. The possibility that the reaction of  AEF with the 
B10.A anti-B10 (anti-Ia.8) antiserum resulted in release of some components that 
were in turn toxic to the cultured cells, has been made unlikely in these studies 
by the use of a direct adsorption method utilizing an immunoadsorbent prepared 
from thoroughly washed glutaraldehyde-linked antibodies. 
The results obtained with the (B6A)F1  anti-B10.D2 antiserum deserve some 
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the  H-2K  region  specificity,  H-2.3I,  but  may  also  be  reactive  with  recently 
determined Iad specificities (5). The capacity of this antiserum to directly absorb 
approximately  45%  of the  AEF  activity  at  the  lowest  concentration  of AEF 
employed (Fig.  1)  could be  interpreted to indicate the reactivity of AEF with 
anti-H-2K antibodies. However, the data presented here are also consistent with 
the  interpretation that  partial  adsorption  by the direct immunoadsorbent  and 
lack of adsorption by the indirect method (in which only a high concentration of 
AEF was incubated with the alloantisera) reflect reactivity of AEF with anti-Ia  d 
antibodies present in this antiserum. 
We conclude, therefore, that the biologically active enhancing moieties of AEF 
bear  Ia  determinants  and  therefore are  most  probably gene  products  of the I 
region of the H-2 gene complex. Recent data from other investigators have shown 
that  an  antigen-specific  T-cell  product  could  be  specifically  adsorbed  by 
immunoadsorbents  prepared  from  antisera  directed  against  the  K  end of H-2 
(16). Since the latter antisera may contain antibodies reactive with specificities 
of both K  and I  regions, it is possible that the use of selective anti-Ia sera may 
yield  results  consistent  with  those  presented  here.  Taken  collectively,  these 
observations indicate that/-region gene products may be intimately involved in 
the  mechanism  of cell-cell  interactions  and  responsible  for the  regulation  of 
immune responses. 
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